Clinical trials show progress in migraine frequency, skin cancer prevention
-
1:00
Author of ’The Help’ meets, discusses newest book in Milwaukee📖
-
2:25
Alders and business owners call out WisDOT for additional planned...
-
2:25
Firefighters battle massive fire at abandoned building near 32nd...
-
2:14
Kenosha father charged in death of own children after Thanksgiving...
-
1:57
’Rescued is my favorite breed’: Thinking about a new furry...
-
2:40
’It’s inappropriate, it’s hateful, it’s hurtful’: Wisconsin...
-
1:14
Steve Stricker deals with emotional, physical blows on path to...
-
0:40
Milwaukee mayor honors city’s heroes at inaugural Peacebuilder...
-
1:05
Racine students create mac-and-cheese domino train before making...
-
4:58
Local health clinic discusses abortion pill access in Wisconsin...
-
0:44
Racine kicks off lead service line replacement program, with...
-
4:39
Extras needed for pilot episode of TV show set in Sheboygan
MILWAUKEE (CBS 58) -- Clinical research studies are aiming to shed new light on the treatment of migraines and skin cancer. One investigates the potential use of a heart device to reduce migraines, while the other seeks to determine the optimal excision size in melanoma treatment.
Dr. Nina Garlie, Vice President of Clinical Trials Research at Aurora Health Care joined us on Thursday, May 25 to discuss these studies.
As part of the National Migraine and Headache Awareness Month in June, Dr. Garlie discussed the link between a particular heart condition and the frequency of migraines.
Also, with the advent of summer and the increased need for skin protection, she also elaborated on a clinical trial addressing skin cancer treatment specifics.
To learn more about the clinical trials and medical research conducted by Aurora Health Care, visit AAH.org/Research.